Chromicent GmbH is a pharmaceutical service provider for chromatographic method development and pharmaceutical analysis. more…

Specialized in: Quality by Design (QbD) and Method LifeCycle Management (MLCM). more…


Method Development

Robust, safe, effective methods using QbD and MLCM


Optimal method transfer through knowledge management report & employee training


Analytical problem solving & robustness testing of established chromatographic methods


Experience meets innovation: Advice on technical and regulatory issues

News from Chromicent

  • Stability Testing
    Stability tests according to ICH Q1A are an established part of Chromicent’s service portfolio. In April, we adapted and expanded the existing range of services to closely meet the wishes … Stability Testing
  • 7 years Chromicent
    7 years of Chromicent – and we say a warm thank you to all our colleagues and companions, customers and friends, and especially to our team. And: Here’s to the … 7 years Chromicent
  • New publication: Nitrosamines
    The first detection of nitrosamines in valsartan preparations took place two years ago. Since then, it has become obvious that the problem of contamination of pharmaceutical products with nitrosamines is … New publication: Nitrosamines
  • BioAccord – Nitrosamines and more
    In response to the increasing demand for large molecule analyses, we at Chromicent are currently testing the BioAccord system from Waters. The background and further information on the BioAccord can … BioAccord – Nitrosamines and more